These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

780 related items for PubMed ID: 11465098

  • 21. Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase.
    Brenner W, Greber I, Gudejko-Thiel J, Beitz S, Schneider E, Walenta S, Peters K, Unger R, Thüroff JW.
    Int J Oncol; 2008 May; 32(5):1125-31. PubMed ID: 18425341
    [Abstract] [Full Text] [Related]

  • 22. CD98 modulates integrin beta1 function in polarized epithelial cells.
    Cai S, Bulus N, Fonseca-Siesser PM, Chen D, Hanks SK, Pozzi A, Zent R.
    J Cell Sci; 2005 Mar 01; 118(Pt 5):889-99. PubMed ID: 15713750
    [Abstract] [Full Text] [Related]

  • 23. The integrin beta1 subunit transmembrane domain regulates phosphatidylinositol 3-kinase-dependent tyrosine phosphorylation of Crk-associated substrate.
    Armulik A, Velling T, Johansson S.
    Mol Biol Cell; 2004 Jun 01; 15(6):2558-67. PubMed ID: 15034138
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Soluble collagen VI induces tyrosine phosphorylation of paxillin and focal adhesion kinase and activates the MAP kinase erk2 in fibroblasts.
    Rühl M, Johannsen M, Atkinson J, Manski D, Sahin E, Somasundaram R, Riecken EO, Schuppan D.
    Exp Cell Res; 1999 Aug 01; 250(2):548-57. PubMed ID: 10413607
    [Abstract] [Full Text] [Related]

  • 30. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.
    Yebra M, Goretzki L, Pfeifer M, Mueller BM.
    Exp Cell Res; 1999 Jul 10; 250(1):231-40. PubMed ID: 10388537
    [Abstract] [Full Text] [Related]

  • 31. Butyrate-treated colonic Caco-2 cells exhibit defective integrin-mediated signaling together with increased apoptosis and differentiation.
    Lévy P, Robin H, Bertrand F, Kornprobst M, Capeau J.
    J Cell Physiol; 2003 Dec 10; 197(3):336-47. PubMed ID: 14566963
    [Abstract] [Full Text] [Related]

  • 32. Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells.
    Slack JK, Adams RB, Rovin JD, Bissonette EA, Stoker CE, Parsons JT.
    Oncogene; 2001 Mar 08; 20(10):1152-63. PubMed ID: 11313859
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A scaffold protein in the c-Jun N-terminal kinase signaling pathway is associated with focal adhesion kinase and tyrosine-phosphorylated.
    Takino T, Yoshioka K, Miyamori H, Yamada KM, Sato H.
    Oncogene; 2002 Sep 19; 21(42):6488-97. PubMed ID: 12226752
    [Abstract] [Full Text] [Related]

  • 35. Cytotoxic T lymphocytes express a beta3 integrin which can induce the phosphorylation of focal adhesion kinase and the related PYK-2.
    Ma EA, Lou O, Berg NN, Ostergaard HL.
    Eur J Immunol; 1997 Jan 19; 27(1):329-35. PubMed ID: 9022036
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pyk2 and Src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully function to enhance FAK- cell migration.
    Sieg DJ, Ilić D, Jones KC, Damsky CH, Hunter T, Schlaepfer DD.
    EMBO J; 1998 Oct 15; 17(20):5933-47. PubMed ID: 9774338
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Differential role of proline-rich tyrosine kinase 2 and focal adhesion kinase in determining glioblastoma migration and proliferation.
    Lipinski CA, Tran NL, Bay C, Kloss J, McDonough WS, Beaudry C, Berens ME, Loftus JC.
    Mol Cancer Res; 2003 Mar 15; 1(5):323-32. PubMed ID: 12651906
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.